Michael S. Weiss - Jan 5, 2024 Form 4 Insider Report for TG THERAPEUTICS, INC. (TGTX)

Role
CEO
Signature
/s/ Michael S. Weiss
Stock symbol
TGTX
Transactions as of
Jan 5, 2024
Transactions value $
$0
Form type
4
Date filed
1/8/2024, 06:32 PM
Previous filing
Jan 3, 2024
Next filing
May 16, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TGTX Common Stock Award $0 +1M +8.3% $0.00 13.1M Jan 6, 2024 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reflects a grant of restricted shares, which will vest and become non-forfeitable based on the Company's total shareholder return relative to the Nasdaq Biotechnology Index over a one-year to five-year period, provided that the Reporting Person remains an employee, director and/or consultant of the Company through each vesting date.
F2 Includes shares of restricted Common Stock, which vest over various time periods.